Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
147.50    -1.50 (-1.01%)
Bid:
145.00
Ask:
150.00
Spread: 5.00 (3.448%)
Market Cap: £45.56m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Board Changes

24 Oct 2023 07:01

RNS Number : 0299R
Gattaca PLC
24 October 2023
 

24 October 2023 

 

Gattaca plc

 

("Gattaca", the "Group")

 

Board Changes

 

 

Gattaca, the specialist staffing solutions business, announces the following Board changes which will take effect immediately following the Group's AGM to be held on the 6 December 2023.

Richard Bradford to succeed Patrick Shanley as Independent Non-Executive Chair

Patrick Shanley, who has been independent Non-Executive Chair of Gattaca since December 2015, has decided to step down from the Board and he will be replaced by Richard Bradford as Independent Non-Executive Chair immediately following the AGM.

Richard has extensive experience in solutions and services businesses, both in the UK and USA. He was Chief Executive of AIM quoted Carlisle Group from 1997 to 2008, up to and including its merger with Corporate Services Group to create Impellam Group. Richard was previously Chief Executive of LPM Group, a private equity backed mid-market group of facilities management investments and began his career with Exel Logistics (now DHL). He is currently chairman of UK based InHealth Group, a leading provider of diagnostics and imaging services, a partner at InHealth Ventures, a London-based transatlantic early-stage digital healthcare fund and deputy chair of the Independent Healthcare Providers Network.

Richard was previously a Non-Executive Director at Gattaca, having originally been appointed in 2011. Since stepping down from the Board in December 2020, he has had no involvement with the business, nor has he previously worked directly with the Group's current Executive directors. As such, the Board have concluded it appropriate that Richard be considered independent.

George Materna, founder and largest shareholder, to step down from the Board

George Materna, the Group's founder and largest shareholder, has decided to retire from the Board and will step down at the AGM. George founded the business nearly 40 years ago and has made a major contribution to the Group. George has been a Non-Executive Director on the Board for over 15 years. He has stated his intention to retain his existing shareholding in the Group.

Ros Haith to step down from the Board

In addition, as the number of non-independent members of the Board will reduce following George Materna's retirement the decision has been taken to further streamline the Board's composition. Accordingly, Ros Haith, who joined the Board in 2021, will step down at the AGM.

This refresh to the Board composition takes place alongside the ongoing implementation of the business transformation plan, focused on developing the Group's four key strategic priorities. Following implementation of these changes, the Board will comprise Matthew Wragg and Oliver Whittaker as CEO and CFO respectively, David Lawther and Tracey James as Independent Non-Executive Directors and led by Richard Bradford as Independent Non-Executive Chair.

Commenting Patrick Shanley, Chair, said:

"Last year we accelerated the changes at Board level with the appointment of Matt Wragg as CEO and Oliver Whitaker as CFO. We were able to do so as succession planning was at the core of our Nomination Committee strategy. Both have settled very well into their roles and are one of the main reasons we feel that now is the right time to reshape the Board to reflect what is required for the next stage of the Group's development. Passing on the baton is never easy, but in Richard we have someone who both knows the business well and can bring a fresh perspective.

"Having founded the business nearly 40 years ago, George felt that as he turned 70, and given his confidence in the Executives, it was a timely opportunity to step down. He has made an outstanding contribution to the business over a very long time. During my time on the Board he has always been supportive and constructive and acted in the interest of all shareholders. He will be sorely missed.

"Lastly, we wish to thank Ros Haith who will also step down at the AGM. Ros has shown her sales pedigree and made a significant contribution to Board discussions. We wish her well in her future endeavours."

Commenting, Richard Bradford, said:

"I am delighted to be re-joining Gattaca. Since my previous association with the Group several years ago, I get a strong sense of progress in systems, people and culture that represent the key ingredients for success.

"Notwithstanding the cyclical nature of the overall staffing sector, the Group is well placed to grow in the STEM markets it serves.

"I look forward to playing my part in helping to deliver future performance and development. I would like to thank Patrick for his contribution to shaping the Group over the past eight years, whilst George's legacy and foundation will never be forgotten. I wish them both well for the future."

Commenting, George Materna, said;

"I founded the business in 1984 and now my primary reason for retiring is that the Board and current management look to be an elite winning team that is restoring and improving on the previously successful culture.

"Working alongside some outstanding people who have contributed to and been important to the success and longevity of the business has been truly fantastic, I thank them all.

"As stated, I will retain my significant shareholding and I look forward to a promising future for the business and the people in it."

 

The following disclosures are required regarding the appointment of Richard James Bradford, aged 60, pursuant to Schedule 2(g) of the AIM Rules for Companies:

Current Directorships/Partnerships

Directorships/Partnerships within last 5 years

E-Locum Services Limited

Gattaca PLC

Euroclinics (UK) Limited

Connect Health Pain Services Holdings Limited

Inhealth (London) Limited

Connect Health Pain Services Limited

Inhealth Group Holdings PLC

Inhealth Group Limited

Inhealth Limited

Inhealth Molecular Imaging Limited

Inhealth Properties Limited

Inhealth Reporting Limited

Medical Imaging Audit and Accreditation Limited

Preventicum UK Limited

Vista Diagnostics Limited

Inhealth Endoscopy Limited

Inhealth Echotech Limited

Inhealth Diagnostic & Imaging Limited

Inhealth Intelligence Limited

Inhealth Cats Limited

London Centre for Advanced Diagnostics Limited

The London Upright MRI Company Limited

United Open MRI Limited

Yorkshire Upright MRI Centre Limited

Independent Healthcare Providers Network (IHPN) Limited

Inhealth Pathology Limited

Prime Endoscopy (Bristol) Limited

Healios Ltd

Inhealth UK Holdings Limited

Tac Healthcare Limited

C7 Health Limited

Diagnostic World Ltd

Tac Healthcare Group Ltd

The Aberdeen Clinic Ltd

Inhealth Audiology and ENT Limited

Cardinal Inhealth Ltd

Inhealth Facilities Management Limited

Lister Inhealth Limited

Inhealth Ventures Limited

 

There are no further disclosures required to be made in respect of the appointment under Schedule 2(g) of the AIM Rules for Companies.

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information please contact:

 

Gattaca plc

+44 (0) 1489 898989

Matthew Wragg, Chief Executive Officer

Oliver Whittaker, Chief Financial Officer

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

Richard Lindley

IFC Advisory

Tim Metcalfe

Graham Herring

Florence Chandler

 

 

+44 (0)20 3934 6630

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFFIIILVFIV
Date   Source Headline
14th May 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 20267:00 amRNSInterim Results
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Feb 20267:00 amRNSTrading Update
31st Dec 20257:00 amRNSDirector/PDMR dealing
31st Dec 20257:00 amRNSDirector/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
16th Dec 202512:19 pmRNSExercise of Options and Director/PDMR Shareholding
11th Dec 20259:05 amRNSResults of Annual General Meeting
10th Nov 20257:00 amRNSAvailability of Report & Accounts and AGM Notice
23rd Oct 20257:00 amRNSFinal results for the year ended 31 July 2025
15th Oct 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
13th Oct 20252:59 pmRNSBlock Listing Six Monthly return
8th Oct 20257:00 amRNSNotice of Results
5th Aug 20257:00 amRNSTrading update and Acquisition
22nd Jul 20257:00 amRNSEBT Share Purchase Programme
21st Jul 20256:22 pmRNSExercise of Options and Director/PDMR Shareholding
2nd Apr 20252:21 pmRNSCORRECTION – Interim Results
2nd Apr 20257:00 amRNSInterim Results
1st Apr 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Feb 20257:00 amRNSTrading Update
27th Jan 20254:51 pmRNSFurther re EBT Share Purchase Programme
11th Dec 20243:59 pmRNSDirector/PDMR Shareholding
11th Dec 20242:25 pmRNSResult of AGM
11th Nov 20242:29 pmRNSAvailability of Report & Accounts and AGM Notice
30th Oct 20247:00 amRNSEBT Share Purchase Programme
24th Oct 20247:00 amRNSFinal results for the year ended 31 July 2024
1st Oct 20247:00 amRNSBlock listing Six Monthly Return
15th Aug 20247:00 amRNSTrading Update for the year ended 31 July 2024
16th Jul 202410:36 amRNSDirector/PDMR Share Purchase
11th Jul 202411:13 amRNSExercise of Options
1st Jul 20247:00 amRNSNominated Adviser and Broker
16th Apr 20247:00 amRNSInterim Results
2nd Apr 20247:00 amRNSBlock listing six monthly return
15th Feb 20247:00 amRNSTrading Update
25th Jan 20247:00 amRNSExercise of Options
6th Dec 20235:07 pmRNSDirector/PDMR Shareholding
6th Dec 20234:51 pmRNSResults of Annual General Meeting
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.